Renaissance Technologies - INVIVO THERAPEUTICS HLDGS CO ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q3 2023$16
-30.4%
13,921
-19.4%
0.00%
Q2 2023$23
+91.7%
17,266
+56.6%
0.00%
Q1 2023$12
-50.0%
11,025
+8.9%
0.00%
Q4 2022$24
-100.0%
10,125
-63.5%
0.00%
Q3 2022$119,00027,7250.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 7,593$8,5040.00%
Milestone Investment Advisors LLC 1$20.00%
Renaissance Technologies 13,921$160.00%
Allworth Financial LP 1$20.00%
VANGUARD GROUP INC 28,938$32,4110.00%
Colonial Trust Advisors 2$20.00%
UBS Group AG 102$1140.00%
Sugarloaf Wealth Management, LLC 1$10.00%
OSAIC HOLDINGS, INC. 6$60.00%
WELLS FARGO & COMPANY/MN 23$260.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders